Suppr超能文献

亚临床和显性甲状腺功能障碍与全因死亡率及心血管事件风险:一项大型人群研究

Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study.

作者信息

Selmer Christian, Olesen Jonas Bjerring, Hansen Morten Lock, von Kappelgaard Lene Mia, Madsen Jesper Clausager, Hansen Peter Riis, Pedersen Ole Dyg, Faber Jens, Torp-Pedersen Christian, Gislason Gunnar Hilmar

机构信息

Department of Cardiology (C.S., J.B.O., M.L.H., P.R.H., G.H.G.), Gentofte University Hospital, DK-2900 Hellerup, Denmark; Department of Endocrinology (C.S., J.F.), Herlev University Hospital, DK-2730 Herlev, Denmark; Copenhagen General Practitioners Laboratory (J.C.M.), DK-2100 Copenhagen, Denmark; Faculty of Health and Medical Sciences (J.F., G.H.G.), University of Copenhagen, DK-2200 Copenhagen, Denmark; Department of Cardiology (O.D.P.), Roskilde University Hospital, DK-4000 Roskilde, Denmark; Institute of Health, Science, and Technology (C.T.-P.), Aalborg University, DK-9220 Aalborg, Denmark; and National Institute of Public Health (L.M.v.K., G.H.G.), University of Southern Denmark, DK-1353 Copenhagen, Denmark.

出版信息

J Clin Endocrinol Metab. 2014 Jul;99(7):2372-82. doi: 10.1210/jc.2013-4184. Epub 2014 Mar 21.

Abstract

CONTEXT

Thyroid dysfunction has been associated with both increased all-cause and cardiovascular mortality, but limited data are available on mild thyroid dysfunction and cause-specific mortality.

OBJECTIVE

The objective of the study was to examine the risk of all-cause mortality, major adverse cardiovascular events (MACEs), and cause-specific events in subjects with overt and subclinical thyroid dysfunction.

DESIGN

This was a retrospective cohort study.

SETTING AND PARTICIPANTS

Participants in the study were subjects who underwent thyroid blood tests, without prior thyroid disease, consulting their general practitioner in 2000-2009 in Copenhagen, Denmark.

MAIN OUTCOME MEASURE

All-cause mortality, MACEs, and cause-specific events identified in nationwide registries were measured.

RESULTS

A total of 47 327 (8.4%) deaths occurred among 563 700 included subjects [mean age 48.6 (SD ± 18.2) y; 39% males]. All-cause mortality was increased in overt and subclinical hyperthyroidism [age adjusted incidence rates of 16 and 15 per 1000 person-years, respectively; incidence rate ratios (IRRs) 1.25 [95% confidence interval (CI) 1.15-1.36] and 1.23 (95% CI 1.16-1.30)] compared with euthyroid (incidence rate of 12 per 1000 person-years). Risk of MACEs was elevated in overt and subclinical hyperthyroidism [IRRs 1.16 (95% CI 1.05-1.27) and 1.09 (95% CI 1.02-1.16)] driven by heart failure [IRRs 1.14 (95% CI 0.99-1.32) and 1.20 (95% CI 1.10-1.31)]. A reduction of all-cause mortality was observed in subclinical hypothyroidism with TSH of 5-10 mIU/L [IRR 0.92 (95% CI 0.86-0.98)].

CONCLUSIONS

Heart failure is the leading cause of an increased cardiovascular mortality in both overt and subclinical hyperthyroidism. Subclinical hypothyroidism with TSH 5-10 mIU/L might be associated with a lower risk of all-cause mortality.

摘要

背景

甲状腺功能障碍与全因死亡率和心血管死亡率增加均相关,但关于轻度甲状腺功能障碍和特定病因死亡率的数据有限。

目的

本研究的目的是探讨显性和亚临床甲状腺功能障碍患者的全因死亡率、主要不良心血管事件(MACE)和特定病因事件的风险。

设计

这是一项回顾性队列研究。

设置与参与者

研究参与者为2000年至2009年在丹麦哥本哈根咨询全科医生的患者,这些患者接受了甲状腺血液检查,且既往无甲状腺疾病。

主要结局指标

测量全国登记处确定的全因死亡率、MACE和特定病因事件。

结果

在纳入的563700名受试者中,共有47327人(8.4%)死亡[平均年龄48.6(标准差±18.2)岁;39%为男性]。与甲状腺功能正常者(每1000人年发病率为12)相比,显性和亚临床甲状腺功能亢进患者的全因死亡率均升高[年龄调整发病率分别为每1000人年16和15;发病率比(IRR)分别为1.25[95%置信区间(CI)1.15 - 1.36]和1.23(95%CI 1.16 - 1.30)]。显性和亚临床甲状腺功能亢进患者的MACE风险升高[IRR分别为1.16(95%CI 1.05 - 1.27)和1.09(95%CI 1.02 - 1.16)],主要由心力衰竭导致[IRR分别为1.14(95%CI 0.99 - 1.32)和1.20(95%CI 1.10 - 1.31)]。TSH为5 - 10 mIU/L的亚临床甲状腺功能减退患者的全因死亡率降低[IRR 0.92(95%CI 0.86 - 0.98)]。

结论

心力衰竭是显性和亚临床甲状腺功能亢进患者心血管死亡率增加的主要原因。TSH为5 - 10 mIU/L的亚临床甲状腺功能减退可能与较低的全因死亡风险相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验